Literature DB >> 26662110

Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.

Ruth Ruiz Esparza-Garrido1,2, María Eugenia Torres-Márquez3, Rubí Viedma-Rodríguez4, Ana Claudia Velázquez-Wong5, Fabio Salamanca-Gómez6, Haydeé Rosas-Vargas5, Miguel Ángel Velázquez-Flores5.   

Abstract

B-cell lymphoma 2 (BCL2)-interacting killer (apoptosis inducing) (BIK) has been proposed as a tumor suppressor in diverse types of cancers. However, BIK's overexpression in breast cancer (BC) and in non-small lung cancer cells (NSCLCs), associated with a poor prognosis, suggests its participation in tumor progression. In this study, we evaluated the global expression pattern of microRNAs (miRNAs), messenger RNA (mRNA) expression changes in autophagy, and autophagic flux after BIK interference. BIK gene expression was silenced by small interfering RNA (siRNA) in BC cell MDA-MB-231, and BIK interference efficiency was tested by real-time PCR and by Western blotting. BIK expression levels decreased by 75 ± 18 % in the presence of 600 nM siRNA, resulting in the abolishment of BIK expression by 94 ± 30 %. BIK interference resulted in the overexpression of 17 miRNAs that, according to the DIANA-miRPath v3.0 database, are mainly implied in the control of cell signaling, gene expression, and autophagy. The autophagy array revealed downregulation of transcripts which participate in autophagy, and their interactome revealed a complex network, where hepatocyte growth factor-regulated tyrosine kinase substrate (HGS), α-synuclein (SNCA), unc-51-like autophagy activating kinase 1/2 (ULK1/2), and mitogen-activated protein kinase 3 (MAPK3) were shown to be signaling hubs. LC3-II expression-an autophagy marker-was increased by 169 ± 25 % after BIK interference, which indicates the involvement of BIK in autophagy. Altogether, our results indicate-for the first time-that BIK controls the expression of miRNAs, as well as the autophagic flux in MDA-MB-231 cells.

Entities:  

Keywords:  Autophagy; BIK; Interactome; MDA-MB-231; MicroRNAs

Mesh:

Substances:

Year:  2015        PMID: 26662110     DOI: 10.1007/s13277-015-4494-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  50 in total

1.  Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study.

Authors:  Zhong-Ling Qiu; Chen-Tian Shen; Hong-Jun Song; Wei-Jun Wei; Quan-Yong Luo
Journal:  Nucl Med Biol       Date:  2015-01-29       Impact factor: 2.408

2.  HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.

Authors:  H M Sowter; P J Ratcliffe; P Watson; A H Greenberg; A L Harris
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

3.  High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.

Authors:  Markus Bredel; Claudia Bredel; Dejan Juric; Griffith R Harsh; Hannes Vogel; Lawrence D Recht; Branimir I Sikic
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

4.  MiR-302/367 regulate neural progenitor proliferation, differentiation timing, and survival in neurulation.

Authors:  Si-Lu Yang; Mei Yang; Stephanie Herrlinger; Chen Liang; Fan Lai; Jian-Fu Chen
Journal:  Dev Biol       Date:  2015-10-09       Impact factor: 3.582

5.  A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

Authors:  Yan Lu; William Lemon; Peng-Yuan Liu; Yijun Yi; Carl Morrison; Ping Yang; Zhifu Sun; Janos Szoke; William L Gerald; Mark Watson; Ramaswamy Govindan; Ming You
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

Review 6.  Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach.

Authors:  Jihoon Nah; Junying Yuan; Yong-Keun Jung
Journal:  Mol Cells       Date:  2015-04-20       Impact factor: 5.034

7.  H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.

Authors:  Constance Vennin; Nathalie Spruyt; Fatima Dahmani; Sylvain Julien; François Bertucci; Pascal Finetti; Thierry Chassat; Roland P Bourette; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Oncotarget       Date:  2015-10-06

8.  Inhibition of autophagy and tumor growth in colon cancer by miR-502.

Authors:  H Zhai; B Song; X Xu; W Zhu; J Ju
Journal:  Oncogene       Date:  2012-05-14       Impact factor: 9.867

9.  miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.

Authors:  Xiaohui Tan; Jin Peng; Yebo Fu; Shejuan An; Katayoon Rezaei; Sana Tabbara; Christine B Teal; Yan-gao Man; Rachel F Brem; Sidney W Fu
Journal:  Breast Cancer Res       Date:  2014-09-17       Impact factor: 6.466

10.  QSOX1 inhibits autophagic flux in breast cancer cells.

Authors:  Laura Poillet; Nicolas Pernodet; Michaël Boyer-Guittaut; Pascale Adami; Christophe Borg; Michèle Jouvenot; Régis Delage-Mourroux; Gilles Despouy
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

View more
  4 in total

1.  Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients.

Authors:  Saskia Mc Langemeijer; Niccolo Mariani; Ruth Knops; Christian Gilissen; Rob Woestenenk; Theo de Witte; Gerwin Huls; Bert A van der Reijden; Joop H Jansen
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

2.  SNCA Is a Functionally Low-Expressed Gene in Lung Adenocarcinoma.

Authors:  Yuanliang Yan; Zhijie Xu; Xiaofang Hu; Long Qian; Zhi Li; Yangying Zhou; Shuang Dai; Shuangshuang Zeng; Zhicheng Gong
Journal:  Genes (Basel)       Date:  2018-01-04       Impact factor: 4.096

3.  Star-PAP, a poly(A) polymerase, functions as a tumor suppressor in an orthotopic human breast cancer model.

Authors:  C Yu; Y Gong; H Zhou; M Wang; L Kong; J Liu; T An; H Zhu; Y Li
Journal:  Cell Death Dis       Date:  2017-02-02       Impact factor: 8.469

4.  The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.

Authors:  Vrajesh Pandya; Darryl Glubrecht; Larissa Vos; John Hanson; Sambasivarao Damaraju; John Mackey; Judith Hugh; Ing Swie Goping
Journal:  Oncotarget       Date:  2016-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.